I-Corps: Non-invasive intracranial pressure sensing

I-Corps：无创颅内压传感

• 批准号: 2321547
• 负责人: Jana Kainerstorfer
• 金额: $ 5万
• 依托单位: Carnegie-Mellon University
• 依托单位国家: 美国
• 项目类别: Standard Grant
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-05-01 至 2023-10-31
• 项目状态: 已结题
• 来源: https://www.nsf.gov/awardsearch/showAward?AWD_ID=2321547&HistoricalAwards=false
• 关键词: Corps; Non; invasive; intracranial; pressure; Corps; Non; invasive; intracranial; pressure

The broader impact/commercial potential of this I-Corps project is the development of a non-invasive method for monitoring intracranial pressure through near-infrared spectroscopy. The current invasive method for measuring intracranial pressure carries a high risk of complications and is not accessible to all patients. The proposed technology aims to provide a cost-effective and easily accessible alternative to the current method. This technology has the potential to improve patient outcomes by enabling early detection of elevated intracranial pressure, thereby allowing for early intervention. The project aims to identify the commercial viability of this technology and explore the potential markets and regulatory processes both domestically and abroad.This I-Corps project is based on the development of a non-invasive alternative to the current invasive method of measuring intracranial pressure. The proposed technology, based on near-infrared spectroscopy, has the potential to significantly improve patient outcomes by enabling early detection of elevated intracranial pressure. This technology uses an optical sensor placed on the forehead of the patient. The project aims to clarify the beachhead market within neurocritical care centers and the attractiveness of markets and regulatory processes abroad.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.

该I-Corps项目的更广泛的影响/商业潜力是开发通过近红外光谱法监测颅内压的非侵入性方法。当前测量颅内压的侵入性方法具有并发症的高风险，所有患者均无法使用。拟议的技术旨在为当前方法提供具有成本效益且易于访问的替代方案。这项技术有可能通过早期检测到颅内压升高，从而提高患者的预后，从而允许早期干预。该项目旨在确定该技术的商业生存能力，并在国内外探索潜在的市场和监管过程。该I-Corps项目基于开发一种非侵入性替代方案，用于目前测量颅内压的侵入性方法。提出的基于近红外光谱法的技术有可能通过早期检测到颅内压的升高来显着改善患者预后。该技术使用放置在患者额头上的光学传感器。该项目旨在澄清神经严峻的护理中心内的海滩市场以及在国外的市场和监管程序的吸引力。该奖项反映了NSF的法定任务，并被认为是值得通过基金会的知识分子优点和更广泛影响的评估来审查标准来通过评估来支持的。